The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort

INTRODUCTION: Hydroxychloroquine (HCQ) is an antimalarial drug that received worldwide news and media attention in the treatment of patients with coronavirus disease 2019 (COVID-19). This drug was used on the basis of its antimicrobial and antiviral properties despite lack of definite evidence of cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulrahman, Abdulkarim, AlSayed, Islam, AlMadhi, Marwa, AlArayed, Jumana, Mohammed, Sara Jaafar, Sharif, Aesha Khalid, Alansari, Khadija, AlAwadhi, Abdulla Ismael, AlQahtani, Manaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822757/
https://www.ncbi.nlm.nih.gov/pubmed/33484407
http://dx.doi.org/10.1007/s40121-021-00397-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822757/
https://www.ncbi.nlm.nih.gov/pubmed/33484407
http://dx.doi.org/10.1007/s40121-021-00397-8

Ejemplares similares